[1]黄晓东　严立冬　杨明环等.胶质瘤CMTM 1、CMTM 6的表达及其临床意义[J].中国临床神经外科杂志,2021,26(12):938-940.[doi:10.13798/j.issn.1009-153X.2021.12.013]
　HUANG Xiao-dong,YAN Li-dong,YANG Ming-huan,et al.Expression of CMTM 1 and CMTM 6 in human glioma tissues and its clinical significance[J].,2021,26(12):938-940.[doi:10.13798/j.issn.1009-153X.2021.12.013]
点击复制

胶质瘤CMTM 1、CMTM 6的表达及其临床意义()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
26
期数:
2021年12期
页码:
938-940
栏目:
论著
出版日期:
2021-12-25

文章信息/Info

Title:
Expression of CMTM 1 and CMTM 6 in human glioma tissues and its clinical significance
文章编号:
1009-153X（2021）12-0938-03
作者:
黄晓东　严立冬　杨明环等
442000 湖北，十堰市太和医院（湖北医药学院附属太和医院）神经外科（黄晓东、严立冬、杨明环、杨博文、张　力、黄宽明、鲁军体），病理科（李　丹）
Author(s):
HUANG Xiao-dong1;  YAN Li-dong1;  YANG Ming-huan1;  LI Dan2;  YANG Bo-wen1;  ZHANG Li1;  HUANG Kuan-ming1;  LU Jun-ti1.
1. Department of Neurosurgery, Shiyan Taihe Hospital, Affiliated Hospital of Hubei Medical College, Shiyan 442000, China; 2. Department of Pathology, Shiyan Taihe Hospital, Affiliated Hospital of Hubei Medical College, Shiyan 442000, China
关键词:
胶质瘤; 趋化素样因子超家族; CMTM1; CMTM6; 预后
Keywords:
Glioma;  CKLF-like MARVEL transmembrane domain-containing family;  CMTM1;  CMTM6;  Prognosis
分类号:
R 739.41; Q 786
DOI:
10.13798/j.issn.1009-153X.2021.12.013
文献标志码:
A
摘要:
目的 探讨趋化素样因子超家族（CMTM）1、CMTM6表达水平与胶质瘤病人预后的关系。方法 收集2016年1月~2019年6月手术切除的胶质瘤组织96例和颅脑损伤内减压术中切除的非肿瘤脑组织40例（对照组），采用免疫组织化学染色检测CMTM1、CMTM6的表达水平。随访24个月，记录胶质瘤病人生存情况。结果 胶质瘤组CMTM1和CMTM6高表达率[分别为64.58%（62/96）、67.71%（65/96）]明显高于对照组[分别为25%（10/40）、20.00%（8/40）；P<0.01]。胶质瘤组织CMTM1与CMTM6表达水平呈正相关（r=0.837，P<0.001）。本文96例随访2年，死亡37例，生存59例。多因素Cox比例回归风险模型分析显示，CMTM1过表达、CMTM6高表达是胶质瘤预后不良的独立危险因素（P<0.05）。生存曲线分析显示，CMTM1、CMTM6高表达组2年累积生存率（分别为50.15%、52.05%）明显低于表达组（分别为79.85%、84.95%；P<0.05）。结论 胶质瘤组织CMTM 1、CMTM 6呈高表达，与病人的不良生存预后有关。
Abstract:
Objective To explore the relationship between the expression levels of CKLF-like MARVEL transmembrane domain-containing family (CMTM) 1 and CMTM6 and the prognosis of glioma patients. Methods The expression levels of CMTM1 and CMTM6 were detected using immunohistochemical staining in glioma tissues obtained from 96 glioma patients (glioma group) who underwent microsurgery and in non-tumor cerebral tissues obtained from 40 patients with traumatic brain injury (control group) who underwent decompression from January 2016 to June 2019. The glioma pstients were followed up for 2 years. Results The high expression rate of CMTM1 and CMTM6 in the glioma group [64.58%(62/96) and 67.71%(65/96), respectively] was significantly higher than those [25%(10/40) and 20.00%(8/40), respectively] in the control group (P<0.05). The expression level of CMTM1 in glioma tissues were positively correlated with CMTM6 expression level (r=0.837, P<0.001). Of 96 glioma patients, 37 patients died and 59 survived 2 years after the operation. Multivariate Cox proportional regression risk model analysis showed that overexpression of CMTM1 and overexpression of CMTM6 were independent risk factors for poor prognosis of glioma patients (P<0.05). Survival curve analysis showed that the 2-year cumulative survival rates of the CMTM1- and CMTM6-high expression groups (50.15% and 52.05%, respectively) were significantly lower than those (79.85% and 84.95%, respectively) of the CMTM1- and CMTM6-low expression groups (P<0.05). Conclusions CMTM 1 and CMTM 6 are highly expressed in glioma tissues and are related to the poor survival prognosis of glioma patients.

参考文献/References:

[1] 赵建辉，胡世颉，李　兵，等. 胶质瘤临床诊疗研究进展[J]. 中华神经外科疾病研究杂志，2017，16（4）：374-377.
[2] 刘宝辉，董慧敏，胡伟国，等. 脑胶质瘤多学科诊疗模式的必要性及策略[J]. 中国临床神经外科杂志，2020，25（10）：731-732.
[3] 付　玮，张　静，丁士刚. CMTM6蛋白与肿瘤发生，发展及预后关系的研究进展[J]. 中国微创外科杂志，2020，20（1）：83-86.
[4] 姚战非，张雪梅，马　枞. 血管内皮生长因子及其受体在人皮肤黑素瘤的组学数据分析[J]. 中国皮肤性病学杂志，2019，33（6）：628-633.
[5] 徐鹏霄，郑淑芳. 免疫组化与分子病理学[M]. 北京：人民军医出版社，2011. 45.
[6] 罗　燕，唐　雪，龚静山，等. 脑胶质瘤放射基因组学研究进展[J]. 国际医学放射学杂志，2018，41（5）：554-557.
[7] Wu J, Li L, Wu S, et al. CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value [J]. Cancer Biol Med, 2020, 17(3): 528-542.
[8] 丁　雨，蒋敬庭. CMTM6在肺腺癌组织中的表达及其临床意义[J]. 中国肿瘤生物治疗杂志，2019，26（5）：544-549.
[9] Delic S, Thuy A, Schulze M, et al. Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets[J]. Gene Chromosome Canc, 2015, 54(7): 433-443.
[10] Imamovic D, Vranic S. Novel regulators of PD-L1 expres-sion in cancer: CMTM6 and CMTM4—a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors [J]. Ann Transl Med, 2017, 5(23): 467.

相似文献/References:

[1]常英男　王　策　赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
　CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(12):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛　克　陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许　耿　路俊锋　杨　忠　施建斌　吴秋月　王　烨　庄冬晓　吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
　XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(12):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰　陈银生　赛　克　张湘衡　柯　超　杨群英　牟永告　许海雄　陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
　LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(12):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波　杨宇焦　张　逵　范润金　张　渊　杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
　YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(12):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚　成于思　王　辉　汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
　HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(12):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林　雨　张　恺　李　帅　杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明　徐成仕　王泽芬　曹长军　李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
　DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(12):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生　田道锋　张申起　陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
　PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(12):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯　驰　郭双毅　程龙海　罗　杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
　FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(12):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]

备注/Memo

备注/Memo:
通讯作者：鲁军体，E-mail：hxdli80@163.com
更新日期/Last Update: 1900-01-01